Medline to Consider Pricing US IPO at $29 Per Share

Medline Inc. is considering pricing its initial public offering at $29 per share, according to people familiar with the matter.

The medical supplies company, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, is discussing a potential upsize to the offering to raise as much as $7 billion, one of the people said, asking not to be identified because the information isn’t public.